Innovative Outcomes (OTC:UBQU) Announces Distribution Agreement With MDM Wound Ventures to Distribute New EZE Debride System to Healthcare Professionals in 4.95 Billion Dollar Market
Innovative Outcomes (OTC:UBQU) Announces Distribution Agreement With MDM Wound Ventures to Distribute New EZE Debride System to Healthcare Professionals in 4.95 Billion Dollar Market
Ubiquitech Software
Ubiquitech 软件
DENVER, CO, April 05, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Ubiquitech Software Corp. (OTC: UBQU) a dynamic and innovative software development company, is pleased to announce that its subsidiary, Innovative Outcomes, Inc., has entered into a distribution agreement with MDM Wound Ventures to distribute its new wound debriding system called EZE Debride to healthcare professionals throughout the US, and beyond.
科罗拉多州丹佛,2024 年 4 月 5 日(GLOBE NEWSWIRE)——通过 NewMediaWir — 充满活力和创新的软件开发公司Ubiquitech Software Corp.(场外交易代码:UBQU)欣然宣布,其子公司Innovative Outcomputes, Inc.已与MDM Wound Ventures签订了分销协议,向美国及其他地区的医疗保健专业人员分发其名为EZE Debride的新型伤口清创系统。
Wound Debriding is the process of removing dead tissue in and around wounds and is vitally important to the healing and long-term care of wound care patients. In addition, proper in-home wound Debriding cuts down on doctor visits saving money for patients and the healthcare system and helps facilitate faster healing giving patients greater flexibility in their own wound care progress.
伤口清创是去除伤口内和周围死组织的过程,对伤口护理患者的愈合和长期护理至关重要。此外,适当的居家伤口清理术可减少就诊次数,为患者和医疗保健系统节省资金,并有助于加快愈合,使患者能够更灵活地进行自己的伤口护理。
Insurance companies require all wounds to have a debridement performed (removal of non-viable tissue) to qualify for insurance reimbursement of wound care dressings. This makes the relationship with MDM and EZE Debride a natural fit. In fact, Modor Intelligence advises the market size for this device to be 4.95 billion with a Compound Annual Growth Rate (CAGR) of 5.97%.
保险公司要求对所有伤口进行清创手术(切除不可存活的组织),才有资格获得伤口护理敷料的保险报销。这使得与 MDM 和 EZE Debride 的关系很自然。实际上,Modor Intelligence建议该设备的市场规模为49.5亿美元,复合年增长率(CAGR)为5.97%。
CEO of Innovative Outcomes, Kevin Lamb, states: "We are excited to distribute this necessary and innovative tool to our healthcare providers and look forward to continued collaboration with MDM Wound Care, and with our current reach into the podiatrist market we see this improving our non-reimbursement revenue exponentially."
创新成果首席执行官凯文·兰姆表示:“我们很高兴向我们的医疗保健提供者分发这种必要的创新工具,并期待与MDM Wound Care继续合作,随着我们目前进入足病医生市场,我们看到这使我们的非报销收入呈指数级增长。”
EZE Debride's revolutionary design is a single use, disposable instrument that offers both comfort and precision. Features include; Cutting flutes, a flexible neck, counter-balance head, and easy to grip handle. Making EZE Debride the leader in the market.
EZE Debride 的革命性设计是一款一次性仪器,既舒适又精确。功能包括:切割长笛、灵活的琴颈、平衡头和易于抓握的手柄。让 EZE Debride 成为市场的领导者。
Follow Ubiquitech Software Corp, Inc. to learn more about Innovative Outcomes and stay informed about Company developments and growth:
关注Ubiquitech Software Corp, Inc.,了解有关创新成果的更多信息,并随时了解公司的发展和增长:
Innovative Outcomes Inc.:
创新成果公司:
Ubiquitech Software Corp.:
Ubiquitech 软件公司:
Follow UBQU on X (Formerly Twitter) @CorporateUBQU
在 X(原推特)上关注 UBQU @CorporateUBQU
Follow Innovative Outcomes on X (Formerly Twitter) @i_outcomes
在 X(前身为 Twitter)上关注创新成果 @i_outcomes
About Ubiquitech Software Corp.
关于Ubiquitech软件公司
Ubiquitech Software Corp utilizes its state-of-the-art global internet marketing, Metaverse marketing, Affiliate marketing, Direct Response (DRTV) Television, Radio, Internet Content, SEO, and traditional marketing to drive traffic to its subsidiary.
Ubiquitech Software Corp 利用其最先进的全球互联网营销、元界营销、联盟营销、直接响应 (DRTV) 电视、广播、互联网内容、SEO和传统营销为其子公司增加流量。
About Innovative Outcomes Inc.
关于创新成果公司
Innovative Outcomes is one of the fastest growing healthcare logistics companies serving medical providers and their patients across the United States. Patients First is more than a catchy phrase - it's our culture.
Innovative Outcomes是增长最快的医疗物流公司之一,为美国各地的医疗提供商及其患者提供服务。“患者至上” 不仅仅是一句朗朗上口的短语,这是我们的文化。
Our mission is simple: provide ethics-based, compassion-focused assistance to medical providers and their patients. Our iPak – unit dose packaging system makes wound care simple and intuitive for all patients.
我们的使命很简单:为医疗服务提供者及其患者提供基于道德的、以同情心为中心的援助。我们的 iPak — 单位剂量包装系统使所有患者的伤口护理变得简单直观。
As a leader in healthcare technology and logistics, we take the worry out of healing.
作为医疗保健技术和物流领域的领导者,我们将康复的烦恼排除在外。
Safe Harbor
安全港
Safe Harbor Provision Cautionary statement for purposes of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995: Information in this news release contains forward-looking statements that involve risks, uncertainties, and assumptions. If such risks or uncertainties materialize or such assumptions prove incorrect, the results of the Company and its consolidated subsidiaries could differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks, uncertainties, and assumptions include the execution and performance of contracts by the Company and its customers, suppliers, and partners. Please also review Ubiquitech Software Corporation, Inc. annual and quarterly financials for a more complete discussion of risk factors. The Company disclaims any obligation to update or revise statements contained in this news release based on new information or otherwise. This communication shall not constitute an offer to sell or the solicitation of an offer to buy securities nor shall there be any sale of these securities in any state in which such solicitation or sale would be unlawful prior to registration or qualification of these securities under the laws of any such state.
就1995年《私人证券诉讼改革法》的 “安全港” 条款而言,安全港条款警告声明:本新闻稿中的信息包含涉及风险、不确定性和假设的前瞻性陈述。如果此类风险或不确定性成为现实,或者此类假设被证明不正确,则公司及其合并子公司的业绩可能与此类前瞻性陈述和假设所表达或暗示的业绩存在重大差异。除历史事实陈述以外的所有陈述均可被视为前瞻性陈述。风险、不确定性和假设包括公司及其客户、供应商和合作伙伴对合同的执行和履行。另请查看Ubiquitech Software Corporation, Inc.的年度和季度财务状况,以更全面地讨论风险因素。公司不承担根据新信息或其他信息更新或修改本新闻稿中包含的声明的任何义务。本通信不应构成卖出要约或征求购买证券要约,在根据任何此类州的法律对这些证券进行注册或资格认定之前,任何州也不得出售此类证券。
Contact / Investor Relations
IR@UbiquitechSoftwareCorp.com
联系方式/投资者关系
IR@UbiquitechSoftwareCorp.com
Attachment
附件
- Ubiquitech Software
- Ubiquitech 软件